SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-23-018414
Filing Date
2023-05-19
Accepted
2023-05-19 17:27:35
Documents
6
Effectiveness Date
2023-05-19

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 107513
2 ex5-1.htm EX-5.1 9808
3 ex23-1.htm EX-23.1 4664
4 ex107.htm EX-FILING FEES 30375
5 ex5-1_002.jpg GRAPHIC 3967
6 ex5-1_001.jpg GRAPHIC 7801
  Complete submission text file 0001493152-23-018414.txt   169877
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272106 | Film No.: 23941646
SIC: 2834 Pharmaceutical Preparations